• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virology . Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic

tetano

Editor, Senior Moderator
Virology


. 2022 Feb 2;568:56-71.
doi: 10.1016/j.virol.2022.01.011. Online ahead of print.
Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic


Ezequiel G Mogro[SUP] 1 [/SUP], Daniela Bottero[SUP] 1 [/SUP], Mauricio J Lozano[SUP] 2 [/SUP]



Affiliations

Abstract

SARS-CoV-2, the seventh coronavirus known to infect humans, can cause severe life-threatening respiratory pathologies. To better understand SARS-CoV-2 evolution, genome-wide analyses have been made, including the general characterization of its codons usage profile. Here we present a bioinformatic analysis of the evolution of SARS-CoV-2 codon usage over time using complete genomes collected since December 2019. Our results show that SARS-CoV-2 codon usage pattern is antagonistic to, and it is getting farther away from that of the human host. Further, a selection of deoptimized codons over time, which was accompanied by a decrease in both the codon adaptation index and the effective number of codons, was observed. All together, these findings suggest that SARS-CoV-2 could be evolving, at least from the perspective of the synonymous codon usage, to become less pathogenic.

Keywords: Betacoronavirus; COVID-19; Codon usage bias; SARS-CoV-2.
 
Back
Top Bottom